Home >
FEATURED COMMENTARY
04 Aug 2015 01:12 PM
Clinical investigation forms the backbone and the history of medical oncology. Cancer clinical trials provide the evidence we need to demonstrate safety and efficacy before Food and Drug...
04 Aug 2015 01:52 PM
I’m sure I am not alone in saying that I am almost obsessively conscious of time. Namely, that there never seems to be enough of it. As busy oncologists, we all have constant demands on our time,...
04 Aug 2015 12:34 PM
Radiation oncology residents and medical oncology fellows interface regularly. Understanding each other’s backgrounds helps improve the care of our mutual patients.
28 Jul 2015 01:42 PM
The auditorium was designed for around 400 people, but only a quarter of the place was occupied. Some people were sitting next to each other; some were hiding alone at the end of the hall.
27 Jul 2015 08:35 AM
I had taken care of her for many years; recommended the adjuvant treatment for her triple-negative breast cancer, then later—walking her through treatment when we found it had recurred in her liver....
14 Jul 2015 10:05 AM
I am a psychiatrist, but I have never regarded myself as a particularly patient one. In fact, I have become even less patient since I was diagnosed with stage IV gastric adenocarcinoma in 2010 and...
13 Jul 2015 01:22 PM
Making poster/abstract discussions a major part of the General Sessions will highlight important developments that might have been missed by the meeting participants, and recognize the efforts of...
01 Jul 2015 06:29 PM
It is my pleasure to introduce you to the Society’s new President, Dr. Julie M. Vose. Dr. Vose brings extensive experience to the job as an internationally recognized expert in the research and...

Latest Comments & Discussions


Roby Antony Thomas, MD
03 Aug 2015 12:41 PM
Agree with you 100%. http://www.ncbi.nlm.nih.gov/pubmed/26098204 https://twitter.com/arifkamalmd/status/613370277771255808  

Vernon K. Sondak, MD
03 Aug 2015 10:08 AM
What is the role of adjuvant therapy in the setting of new, more effective therapies for metastatic melanoma? Login to answer here....

Juliao A. C. Monteiro, MD
02 Aug 2015 09:42 PM
Our daily life as oncologists. 

ASCO University
29 Jul 2015 02:20 PM
Thank you to Drs. Petrylak and Netto leading the discussion of this case and also to all of those who contributed to the conversation! The...

Daniel Peter Petrylak, MD
29 Jul 2015 02:05 PM
Thank you everyone for the interest in this discussion.  These are my take away points based off of the information: ...

Pages

Most Read

A study out of the Smilow Cancer Hospital (SCH) in New Haven, Connecticut, assessed the outcomes of an intervention designed to address barriers clinicians face in documenting patients’ emotional distress. The study, “Incorporating Patient-Reported Outcomes to Improve Emotional Distress Screening...
I had taken care of her for many years; recommended the adjuvant treatment for her triple-negative breast cancer, then later—walking her through treatment when we found it had recurred in her liver. We had hoped for a long-lasting remission, but then she developed bone and lung metastases.
Drawing upon the experience and support of palliative care consultants can be a great way to bring their expertise to bear on a difficult clinical situation.
ASCO presents Special Awards to recognize individuals who have made significant contributions to ASCO, the practice of clinical oncology, people with cancer, or activities that impact public awareness about cancer, its causes, cures, or treatment. All ASCO members are encouraged to take a moment...
I’m sure I am not alone in saying that I am almost obsessively conscious of time. Namely, that there never seems to be enough of it. As busy oncologists, we all have constant demands on our time, from our leadership, colleagues, drug company reps, insurers, and our families, not to mention the time...

Tweets from ASCO

Tweets from Oncology Community